US 7,465,459 B2 · Piroplasmid vaccine

Abstract

The invention relates to a Piroplasmid protein or an immunogenic fragment of the protein, and to a nucleic acid encoding the Piroplasmid protein or the immunogenic fragment. Furthermore, the invention relates to cDNA fragments, recombinant DNA molecules and live recombinant carriers comprising the nucleic acid. Also the invention relates to host cells comprising the cDNA fragments, recombinant DNA molecules and live recombinant carriers. Finally, the invention relates to vaccines comprising a Piroplasmid protein or an immunogenic fragment of the protein, to methods for the preparation of such vaccines, to the use of such proteins or fragments for vaccine purposes, and to diagnostic tests.

Claims13

Dependent claims

An isolated protein comprising an amino acid sequence selected from the group consisting of:

SEQ ID NO:
2 and
immunogenic fragments of SEQ ID NO:
2,
wherein said protein elicits the production of antibodies that interfere with invasion by Babesia bovis into erythrocytes.

2 more elements

Dependencies are inferred from the claim text.

Piroplasmid vaccine

Life of this patent

Piroplasmid vaccine

Life of this patent

Abstract

Claims13